Royal Bank Of Canada Abcam PLC Transaction History

Royal Bank Of Canada

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$21.54 - $24.41 $3.52 Million - $3.99 Million	-163,502 Reduced 10.36%	1,415,008 $32 Million
Q2 2023 Aug 14, 2023	BUY	$12.62 - $24.47 $521,041 - $1.01 Million	41,287 Added 2.69%	1,578,510 $38.6 Million
Q1 2023 May 15, 2023	SELL	$12.98 - $17.1 $36,084 - $47,538	-2,780 Reduced 0.18%	1,537,223 $20.7 Million
Q4 2022 Feb 14, 2023	BUY	$13.92 - $17.0 $13.8 Million - $16.9 Million	992,841 Added 181.45%	1,540,003 $24 Million
Q3 2022 Nov 14, 2022	SELL	$13.36 - $16.75 $22,244 - $27,888	-1,665 Reduced 0.3%	547,162 $8.2 Million
Q2 2022 Aug 15, 2022	BUY	$12.69 - $19.25 $445,279 - $675,463	35,089 Added 6.83%	548,827 $7.94 Million
Q1 2022 May 16, 2022	BUY	$15.5 - $23.89 $332,010 - $511,723	21,420 Added 4.35%	513,738 $9.4 Million
Q4 2021 Feb 14, 2022	BUY	$20.04 - $23.84 $755,067 - $898,243	37,678 Added 8.29%	492,318 $11.6 Million
Q3 2021 Nov 15, 2021	BUY	$17.38 - $21.54 $652,028 - $808,094	37,516 Added 8.99%	454,640 $9.22 Million
Q2 2021 Aug 16, 2021	BUY	$18.47 - $22.11 $7.7 Million - $9.22 Million	417,124 New	417,124 $7.94 Million

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.